JMPWA
VAXX

JP Morgan Private Wealth Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-199,022
Closed -$394K – 2015
2022
Q3 		$394K Buy
+199,022
New +$414K ﹤0.01% 1551

Other funds holding VAXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Private Wealth Advisors's VAXX Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2022, closing a stake of 199,022 shares — an estimated $394K sold.

JP Morgan Private Wealth Advisors first reported a position in VAXX in Q3 2022 and held it in 1 quarter. The position peaked at $394K in Q3 2022. 30 funds tracked by Wall St. Rank hold VAXX as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 199,022 Vaxxinity, Inc. Class A Common Stock shares in Q4 2022, an estimated $394K.
  • JP Morgan Private Wealth Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $394K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.